Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This prevents the sharp sugar spikes and subsequent hunger cravings that can derail weight loss efforts
Holst reflects on the multi-decade journey from the discovery of GLP-1 in 1986 to its current use as a weekly injectable drug
These high prices make it essential to explore potential discounts and savings programs
Additional Cost Management Strategies Organizations exploring GLP-1 coverage are also considering targeted cost-control measures, including: Setting clinical qualification standards based on BMI and related conditions Establishing duration or lifetime coverage limits where allowed Adjusting copays or deductibles for obesity-related medications Favoring lower-utilization or lower-cost therapeutic alternatives within the formulary Evaluating alternative treatments such as bariatric surgery, which may produce durable outcomes at comparable costs to a year of medication therapy These strategies allow employers to maintain access while aligning coverage with financial objectives
They are the architecture that makes the clinical outcomes possible
